New Zealand shares rose, boosted by news that health appliance firm ResMed has dropped a complaint against Fisher & Paykel Healthcare at the US International Trade Commission, and offsetting largely tepid trading as weak international leads sidelined many investors.
A slide in dual-listed Australia & New Zealand Banking Group and Westpac Banking Group also weighed on the bourse.
The S&P/NZX 50 Index increased 14.89 points or 0.2 per cent to 7,422.50. Within the index, 15 stocks rose, seven were unchanged and 28 fell. Turnover was $151.9 million.
Fisher & Paykel Healthcare added 1.7 per cent to $10.18, helping the market outperform much of Asia, where concerns about US President Donald Trump's administration hurt investor sentiment.
Markets were jittery after reports Trump asked then-FBI Director James Comey to end a probe into the White House's former national security adviser, and raised questions over whether obstruction of justice charges could be laid against Trump.